Tag: Atraverse
Atraverse showcases findings indicating mitigated left atrial injury and reduced RF...
Atraverse Medical has announced the presentation of new clinical and preclinical data at the 2026 AF symposium (5–7 February, Boston, USA), further validating the...
Atraverse secures US FDA clearance for Hotwire transseptal access system
Atraverse Medical has received 510(k) clearance from the US Food and Drug Administration (FDA) for its fully integrated Hotwire transseptal access system.
The novel system...
Atraverse closes US$29 million to boost commercialisation of Hotwire transseptal access...
Atraverse Medical has announced the close of US$29.4 million in follow-on financing to accelerate growth, building upon the US$12.5 million in prior seed investment...
Atraverse presents clinical data on Hotwire transseptal access system at HRS...
Atraverse Medical has announced that the latest clinical evidence on the efficacy and safety of its Hotwire left heart access system were presented at...
Atraverse announces clinical evidence validating Hotwire radiofrequency guidewire system
Clinical evidence supporting the efficacy, safety and efficiency of Atraverse Medical's Hotwire left-heart access system was presented recently at the 30th annual AF symposium...
Atraverse announces first clinical use of Hotwire RF guidewire system
The Hotwire radiofrequency (RF) guidewire device from Atraverse Medical has been used for the first time in clinical practice by world-renowned cardiac electrophysiologist Devi Nair...